false
OasisLMS
Catalog
Medical Review Officer Online Course with Live Dis ...
2024 January MRO Live Discussion
2024 January MRO Live Discussion
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, a group of faculty members discuss various topics related to drug testing in the workplace. They begin with a discussion on follow-up testing programs for commercial drivers, specifically in the case of a driver who has left their CDL position but is still under a substance abuse professional (SAP) program. The participants explain that while the driver is not required to continue with testing while not in a safety-sensitive position, their future employer will need to check their drug testing history and continue any unfinished follow-up testing. They also clarify that the responsibility for scheduling these tests lies with the employer. The conversation then shifts to the recent increase in the cutoff level for morphine in the Department of Health and Human Services (HHS) guidelines and its implications for DOT testing. The faculty members explain that while DOT has not implemented this change yet, there is an ongoing discussion on how to proceed. They also highlight the challenges of tracking follow-up tests and the importance of documentation. The discussion concludes with a brief mention of the differences between federally regulated testing and non-regulated testing, particularly regarding marijuana positive results. Overall, the participants provide insights into specific scenarios and address questions related to drug testing in the workplace.
Keywords
drug testing
workplace
follow-up testing
commercial drivers
substance abuse professional
DOT testing
HHS guidelines
federally regulated testing
×
Please select your language
1
English